Dexmedetomidine in Off Pump Coronary Artery Bypass Grafting
Status:
Not yet recruiting
Trial end date:
2023-03-30
Target enrollment:
Participant gender:
Summary
the study will assess the impact of intraoperative dexmedetomidine infusion on myocardial
performance by investigating the left ventricular (LV) systolic and diastolic function and
right ventricular (RV) fraction area change (which reflect RV systolic function) using
two-dimensional trans-esophageal echocardiography (TEE) in patients undergoing elective
first-time isolated off-pump coronary artery bypass (OPCAB) grafting. LV Systolic function
will be measured by the TEE via the fractional area change, fraction shortening, and ejection
fraction.